Sign in
4

Changes in Ownership

Zentalis Pharmaceuticals, Inc. Filed Acc 0000902664-25-005288

10% owner sold 7,500,000 shares at $1.33 ($9,975,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Matrix Capital Management Company, LP 10% owner 2025-12-15 Sale −7,500,000 $1.33 $9,975,000 6,459,973 I
Open-market sales · 7,500,000 sh · avg $1.33 · $9,975,000
Loading xslF345X05/ownership.xml…